Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook ...

IT’S hard not to notice the amount of male celebrities who have stepped out sporting a much slimmer frame and chiselled ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...

For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That ...

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...